Recently, we found that the levels of CaR, Gα12 and p115RhoGEF expression are significantly up-regulated in AR-deficient and highly metastatic prostate cancer cells and prostate tumor specimens [26]. Here, ARHGEF1 is linked to prostate carcinoma.